Evidence map›Paper›PMID 31416423›Full record

ArticleBMC genomics2019

Evaluating the quality of the 1000 genomes project data.

Saurabh Belsare, Michal Levy-Sakin, Yulia Mostovoy, Steffen Durinck, Subhra Chaudhuri, Ming Xiao, Andrew S Peterson, Pui-Yan Kwok, Somasekar Seshagiri, Jeffrey D Wall

Abstract read
In one paragraph

Article in BMC genomics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  2. A recurrentBiochemistry and biophysics reports · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Saurabh BelsareInstitute for Human Genetics, University of California, San Francisco, CA, 94143, USA. saurabh.belsare@ucsf.edu.ORCID http://orcid.org/0000-0002-8148-1867
Michal Levy-SakinDepartment of Dermatology, University of California, San Francisco, CA, 94143, USA.
Yulia MostovoyDepartment of Dermatology, University of California, San Francisco, CA, 94143, USA.
Steffen DurinckDepartment of Molecular Biology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
Subhra ChaudhuriDepartment of Molecular Biology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
Ming XiaoSchool of Biomedical Science, Engineering, and Health Systems, Drexel University, Philadelphia, PA, 19104, USA.
Andrew S PetersonDepartment of Molecular Biology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
Pui-Yan KwokInstitute for Human Genetics, University of California, San Francisco, CA, 94143, USA.
Somasekar SeshagiriDepartment of Molecular Biology, Genentech Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
Jeffrey D WallInstitute for Human Genetics, University of California, San Francisco, CA, 94143, USA. jeff.wall@ucsf.edu.

Funding

Single molecule DNA mapping for genome and CNV analysisR01HG005946 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KWOK, PUI-YAN, XIAO, MING · 2010 to 2021
$6.5M
Estimating fine scale changes in recombination rates across speciesR01GM115433 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WALL, JEFFREY D · 2015 to 2018
$1.2M
NHGRI NIH HHS R01 HG005946NIGMS NIH HHS R01 GM115433
6 · The paper itself

Abstract

backgroundData from the 1000 Genomes project is quite often used as a reference for human genomic analysis. However, its accuracy needs to be assessed to understand the quality of predictions made using this reference. We present here an assessment of the genotyping, phasing, and imputation accuracy data in the 1000 Genomes project. We compare the phased haplotype calls from the 1000 Genomes project to experimentally phased haplotypes for 28 of the same individuals sequenced using the 10X Genomics platform.

resultsWe observe that phasing and imputation for rare variants are unreliable, which likely reflects the limited sample size of the 1000 Genomes project data. Further, it appears that using a population specific reference panel does not improve the accuracy of imputation over using the entire 1000 Genomes data set as a reference panel. We also note that the error rates and trends depend on the choice of definition of error, and hence any error reporting needs to take these definitions into account.

conclusionsThe quality of the 1000 Genomes data needs to be considered while using this database for further studies. This work presents an analysis that can be used for these assessments.

Indexed as

Gene FrequencyGenome, HumanHaplotypesHigh-Throughput Nucleotide SequencingHuman Genome ProjectHumansPolymorphism, Single NucleotideRacial GroupsScientific Experimental Error1000 genomesImputationPhasing

Identifiers

PMID31416423
PMCPMC6696682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.